Related Experiment Videos
[Inheritance in neoplastic urogenital pathology]
1Cattedra di Urologia 1, Dipartimento di Discipline Medico-Chirurgiche, Università degli Studi di Torino, Torino, Italy.
Summary
Advances in molecular biology and genetic techniques have improved the identification of cancer-predisposing genes, paving the way for gene therapy and improved prevention strategies for hereditary urogenital tumors.
Area of Science:
- Molecular biology
- Genetics
- Oncology
Context:
- Significant progress in molecular biology has enhanced understanding of chromosomal aberrations in hereditary and sporadic tumors.
- New techniques like FISH and CGH aid in identifying oncogenes and oncosuppressor genes.
Purpose:
- To review advances in the genetics of urogenital hereditary tumors.
- To highlight the role of genetic research in cancer therapy and prevention.
Summary:
- Molecular biology advancements have led to new techniques for identifying cancer-predisposing genes.
- Gene therapy, including gene-replacement and small interfering RNAs, represents a key translational research area.
- Chemoprevention trials are being conducted for hereditary prostate cancer.
Impact:
- Improved identification of genetic predispositions for urogenital cancers.
- Potential for more effective gene-directed therapies and preventative measures.
- Translational research bridging laboratory findings to clinical practice.